Sugi Predict

Sugi Predict / Compounds / SCHEMBL21749191

SCHEMBL21749191

SCHEMBL21749191

Cc1nc2cc(-c3ccc(Cl)cc3Cl)nn2c(N2CCC[C@](C(=O)O)(C(C)C)C2)c1C(C)C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 12/20 0.39
▸ DPP8 Q6V1X1 7/20 0.39
▸ DPP9 Q86TI2 5/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ABCB1 P08183 2/20 0.36
▸ CRHR1 P34998 2/20 0.35
▸ KMT2A Q03164 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ DPP7 Q9UHL4 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21775753 1.00 DPP4 (0.39) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL21775866 1.00 DPP4 (0.39) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL20503094 0.91 HPGD (0.41) DPP4DPP8ABCB1KMT2ANPSR1
SCHEMBL21749199 0.91 HPGD (0.41) DPP4DPP8ABCB1KMT2ANPSR1
SCHEMBL21749208 0.91 HPGD (0.41) DPP4DPP8ABCB1KMT2ANPSR1
SCHEMBL21774099 0.90 ABCB1 (0.34) DPP4DPP8DPP9ABCB1DPP7
SCHEMBL21775748 0.90 ABCB1 (0.34) DPP4DPP8DPP9ABCB1DPP7
SCHEMBL21775614 0.89 DGAT1 (0.40) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL21775745 0.89 DGAT1 (0.40) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL21775867 0.89 DGAT1 (0.40) DPP4DPP8DPP9CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 — — US claimed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 — — US claimed
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 — — US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives GABRA5, P2RX5, P2RY1 DPP4 721/4885DPP8 1147/4885DPP9 850/4885
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives GABRA5, P2RX5, P2RY1 DPP4 721/4885DPP8 1147/4885DPP9 850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.